The FDA warns Baxter International about problems with its HomeChoice dialysis device and with drug infusion pumps made at a pair of plants. The FDA sent warning letters to Baxter (NYSE:BAX) this year, flagging infractions at an Illinois plant where Baxter makes its HomeChoice dialysis device and at a California plant that makes drug infusion pumps. In a warning letter sent Jan. 17 and posted by the FDA Feb. 10, the watchdog agency flagged 6 violations discovered during inspections last summer of Baxter’s Round Lake, Ill., HomeChoice plant.
Help employers find you! Check out all the jobs and post your resume.
